Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Nov;43(11):833-42.
doi: 10.1136/jmg.2006.042796. Epub 2006 Jul 6.

The cardiofaciocutaneous syndrome

A Roberts  1 , J Allanson, S K Jadico, M I Kavamura, J Noonan, J M Opitz, T Young, G Neri
Affiliations
Review

The cardiofaciocutaneous syndrome

A Roberts et al. J Med Genet. 2006 Nov.

Abstract

The cardiofaciocutaneous (CFC) syndrome is a condition of sporadic occurrence, with patients showing multiple congenital anomalies and mental retardation. It is characterised by failure to thrive, relative macrocephaly, a distinctive face with prominent forehead, bitemporal constriction, absence of eyebrows, hypertelorism, downward-slanting palpebral fissures often with epicanthic folds, depressed nasal root and a bulbous tip of the nose. The cutaneous involvement consists of dry, hyperkeratotic, scaly skin, sparse and curly hair, and cavernous haemangiomata. Most patients have a congenital heart defect, most commonly pulmonic stenosis and hypertrophic cardiomyopathy. The developmental delay usually is moderate to severe. The syndrome is caused by gain-of-function mutations in four different genes BRAF, KRAS, mitogen-activated protein/extracellular signal-regulated kinase MEK1 and MEK2, all belonging to the same RAS-extracellular signal-regulated kinase (ERK) pathway that regulates cell differentiation, proliferation and apoptosis. The CFC syndrome is a member of a family of syndromes that includes the Noonan and Costello syndromes, presenting with phenotypic similarities. Noonan syndrome is caused by mutations in the protein tyrosine phosphatase SHP-2 gene (PTPN11), with a few people having a mutation in KRAS. Costello syndrome is caused by mutations in HRAS. The protein products of these genes also belong to the RAS-ERK pathway. Thus, the clinical overlap of these three conditions, which often poses a problem of differential diagnosis, is explained by their pathogenetic relatedness.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Reynolds J F, Neri G, Herrmann J P, Blumberg B, Coldwell J G, Miles P V, Opitz J M. New multiple congenital anomalies/mental retardation syndrome with cardio‐facio‐cutaneous involvement—the CFC syndrome. Am J Med Genet 198628413–427. - PubMed
    1. Weiss G, Confino Y, Shemer A, Trau H. Cutaneous manifestations in the cardiofaciocutaneous syndrome, a variant of the classical Noonan syndrome. Report of a case and review of the literature. J Eur Acad Derm Vener 200418324–327. - PubMed
    1. Fryer A E, Holt P J, Hughes H E. The cardio‐facio‐cutaneous syndrome and Noonan syndrome: are they the same? Am J Med Genet 199138548–551. - PubMed
    1. Neri G, Zollino M, Reynolds J F. The Noonan‐CFC controversy. Am J Med Genet 199139367–370. - PubMed
    1. Ward K A, Moss C, McKeown C. The cardio‐facio‐cutaneous syndrome: a manifestation of the Noonan syndrome? Br J Dermatol 1994131270–274. - PubMed

MeSH terms